Principal Biotechnology Discovery Fund.
Biotechnology: The Building Block of a New World.

Principal Biotechnology Discovery Fund works to your benefit

From emerging pharmaceuticals to life science companies, the Principal Biotechnology Discovery Fund provides investors with exposure to all market caps in the biotechnology sector. The fund aims to achieve capital appreciation through investments in a single collective investment scheme, which invests in biotechnology related securities that is potentially set to grow with future opportunities.
 

Why Biotechnology?

 

#1 Outpacing other sectors
Amid the pandemic, the sector showed significant progress and outgrew other sectors. 

#2 Improving lives & health
From vaccines and cancer treatments to immunology and gene editing, biotechnology is making waves in all the right places.
 

#3 Compelling investment landscape
At 33%, health makes up a sizable chunk of the biotechnology investment landscape¹.

 

Opportunities in Biotechnology?

Long-term growth drivers in biotechnology remain intact

   

1. Source: Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER). As of 22 January 2021.
2. Source: Bloomberg LP. As of 31 December 2019. Based on holdings in the NASDAQ Biotechnology Index from 2009 through 2019.

Recent advancements in areas such as data processing, cloud computing, machine learning, and artificial intelligence are paving way for a fusion of:

Explore more, here's a view of the vast potential of biotechnology:

Biotech - Leading the health care industry in investment activity

Biotech sales growth outpaced other sectors

Investors now have a larger opportunity set to position themselves in medical biotech

Why invest with Principal?

Fund Partners 

• Affin Bank Berhad
• HSBC Bank (Malaysia) Berhad
• iFAST Capital Sdn Bhd
• AmBank (M) Berhad
• Phillip Mutual Berhad
• UOB Kay Hian Securities (M) Sdn Bhd
• Principal Unit Trust Scheme Consultants

Click here to know more about our fund partner(s).

Disclaimer: We recommend that you read and understand the contents of the Prospectus for Principal Biotechnology Discovery Fund dated 15 September 2021 which has been duly registered with the Securities Commission Malaysia (SC) before investing and that you keep the said Prospectus for your record. Any issue of units to which the Prospectus relates will only be made upon receipt of the completed application form referred to in and accompanying the Prospectus, subject to the terms and conditions therein. Investments in the Fund are exposed to risks. You should understand the risks, make your own risk assessment, and seek professional advice, where necessary. You can obtain copies of the Prospectus from the head office of Principal Asset Management Berhad, our website at www.principal.com.my or from any of our approved distributors. There are fees and charges involved in investing in the funds. We suggest that you consider these fees and charges carefully prior to making an investment. Investors have the right to request for the Prospectus, Product Highlights Sheet (PHS) and any other product disclosure document; and the documents should be read and understood before making any investment decision. Unit prices and income distributions, if any, may fall or rise. Past performance is not reflective of future performance and income distributions are not guaranteed. You are also advised to read and understand the contents of the Financing for Investments in Unit Trust Risk Disclosure Statement before deciding to obtain financing to purchase units. The registration of the Prospectus with the SC does not amount to nor indicate that the SC recommends or endorses the fund, and the SC does not review advertisements produced by Principal.